Hypertension:不容错过!高血压儿童降压药的更佳选择

2018-08-15 吴星 环球医学

对生活方式的改变反应迟钝的高血压儿童和青少年进行药物治疗,但没有充足的证据推荐首选1级降压药物。2018年8月,发表在《Hypertension》的一项网络荟萃分析,比较现有关于儿童高血压药物治疗的随机临床试验的结局。

对生活方式的改变反应迟钝的高血压儿童和青少年进行药物治疗,但没有充足的证据推荐首选1级降压药物。2018年8月,发表在《Hypertension》的一项网络荟萃分析,比较现有关于儿童高血压药物治疗的随机临床试验的结局。

从共计554项潜在相关研究中,纳入13项随机安慰剂对照临床研究,这些研究均涉及≥50例患者,随访时间≥4周。治疗后收缩压(SBP)和舒张压(DBP)的降低为共同主要终点。

分析共纳入2378例儿童患者,中位年龄为12岁。在中位随访35天后,研究者发现赖诺普利和依那普利在降低SBP和DBP方面优于安慰剂,而对于DBP而言,氯沙坦优于安慰剂,赖诺普利和依那普利优于依普利酮。与安慰剂相比,血管紧张素转化酶抑制剂和血管紧张素受体阻断剂与更大幅度的SBP和DBP降低相关。同样,盐皮质激素受体拮抗剂在降低DBP方面劣于血管紧张素转化酶抑制剂。这项分析校正了研究层面的平均年龄、女性比例、平均基线血压,以及平均体重,只有后者显著影响DBP降低。

根据目前的分析,血管紧张素转化酶抑制剂和血管紧张素受体阻断剂代表着儿童高血压降压治疗的最佳选择。然而,由于缺乏其他类型降压药的相关数据,尚不能得出明确的结论,需要进一步的随机对照试验来证实。

原始出处:

Burrello J, Erhardt EM, Saint-Hilary G, et.al. Pharmacological Treatment of Arterial Hypertension in Children and Adolescents: A Network Meta-Analysis. Hypertension. 2018 Aug;72(2):306-313. doi: 10.1161/HYPERTENSIONAHA.118.10862. Epub 2018 Jul 2.

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1727531, encodeId=df131e2753186, content=<a href='/topic/show?id=986913980dd' target=_blank style='color:#2F92EE;'>#PE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13980, encryptionId=986913980dd, topicName=PE)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f06c33759375, createdName=feather89, createdTime=Mon Apr 29 04:50:00 CST 2019, time=2019-04-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2038965, encodeId=eb2320389654e, content=<a href='/topic/show?id=b45d1e274e8' target=_blank style='color:#2F92EE;'>#TENS#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17274, encryptionId=b45d1e274e8, topicName=TENS)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3b172500206, createdName=12498ebem19暂无昵称, createdTime=Wed Jun 26 12:50:00 CST 2019, time=2019-06-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1291986, encodeId=87f412919867b, content=<a href='/topic/show?id=9d32981418b' target=_blank style='color:#2F92EE;'>#降压#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=98141, encryptionId=9d32981418b, topicName=降压)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8f14236, createdName=经常头晕, createdTime=Fri Aug 17 00:50:00 CST 2018, time=2018-08-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1501323, encodeId=259a1501323c3, content=<a href='/topic/show?id=f2db9238f9' target=_blank style='color:#2F92EE;'>#Hypertension#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=9238, encryptionId=f2db9238f9, topicName=Hypertension)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=11ff9497046, createdName=jambiya, createdTime=Fri Aug 17 00:50:00 CST 2018, time=2018-08-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=338752, encodeId=40ae338e5241, content=儿童高血压的治疗。, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/07/16/3b24606172648eea459125cb74754afe.jpg, createdBy=6c022216608, createdName=liumin1987, createdTime=Wed Aug 15 11:39:24 CST 2018, time=2018-08-15, status=1, ipAttribution=)]
    2019-04-29 feather89
  2. [GetPortalCommentsPageByObjectIdResponse(id=1727531, encodeId=df131e2753186, content=<a href='/topic/show?id=986913980dd' target=_blank style='color:#2F92EE;'>#PE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13980, encryptionId=986913980dd, topicName=PE)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f06c33759375, createdName=feather89, createdTime=Mon Apr 29 04:50:00 CST 2019, time=2019-04-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2038965, encodeId=eb2320389654e, content=<a href='/topic/show?id=b45d1e274e8' target=_blank style='color:#2F92EE;'>#TENS#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17274, encryptionId=b45d1e274e8, topicName=TENS)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3b172500206, createdName=12498ebem19暂无昵称, createdTime=Wed Jun 26 12:50:00 CST 2019, time=2019-06-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1291986, encodeId=87f412919867b, content=<a href='/topic/show?id=9d32981418b' target=_blank style='color:#2F92EE;'>#降压#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=98141, encryptionId=9d32981418b, topicName=降压)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8f14236, createdName=经常头晕, createdTime=Fri Aug 17 00:50:00 CST 2018, time=2018-08-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1501323, encodeId=259a1501323c3, content=<a href='/topic/show?id=f2db9238f9' target=_blank style='color:#2F92EE;'>#Hypertension#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=9238, encryptionId=f2db9238f9, topicName=Hypertension)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=11ff9497046, createdName=jambiya, createdTime=Fri Aug 17 00:50:00 CST 2018, time=2018-08-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=338752, encodeId=40ae338e5241, content=儿童高血压的治疗。, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/07/16/3b24606172648eea459125cb74754afe.jpg, createdBy=6c022216608, createdName=liumin1987, createdTime=Wed Aug 15 11:39:24 CST 2018, time=2018-08-15, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1727531, encodeId=df131e2753186, content=<a href='/topic/show?id=986913980dd' target=_blank style='color:#2F92EE;'>#PE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13980, encryptionId=986913980dd, topicName=PE)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f06c33759375, createdName=feather89, createdTime=Mon Apr 29 04:50:00 CST 2019, time=2019-04-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2038965, encodeId=eb2320389654e, content=<a href='/topic/show?id=b45d1e274e8' target=_blank style='color:#2F92EE;'>#TENS#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17274, encryptionId=b45d1e274e8, topicName=TENS)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3b172500206, createdName=12498ebem19暂无昵称, createdTime=Wed Jun 26 12:50:00 CST 2019, time=2019-06-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1291986, encodeId=87f412919867b, content=<a href='/topic/show?id=9d32981418b' target=_blank style='color:#2F92EE;'>#降压#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=98141, encryptionId=9d32981418b, topicName=降压)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8f14236, createdName=经常头晕, createdTime=Fri Aug 17 00:50:00 CST 2018, time=2018-08-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1501323, encodeId=259a1501323c3, content=<a href='/topic/show?id=f2db9238f9' target=_blank style='color:#2F92EE;'>#Hypertension#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=9238, encryptionId=f2db9238f9, topicName=Hypertension)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=11ff9497046, createdName=jambiya, createdTime=Fri Aug 17 00:50:00 CST 2018, time=2018-08-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=338752, encodeId=40ae338e5241, content=儿童高血压的治疗。, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/07/16/3b24606172648eea459125cb74754afe.jpg, createdBy=6c022216608, createdName=liumin1987, createdTime=Wed Aug 15 11:39:24 CST 2018, time=2018-08-15, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1727531, encodeId=df131e2753186, content=<a href='/topic/show?id=986913980dd' target=_blank style='color:#2F92EE;'>#PE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13980, encryptionId=986913980dd, topicName=PE)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f06c33759375, createdName=feather89, createdTime=Mon Apr 29 04:50:00 CST 2019, time=2019-04-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2038965, encodeId=eb2320389654e, content=<a href='/topic/show?id=b45d1e274e8' target=_blank style='color:#2F92EE;'>#TENS#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17274, encryptionId=b45d1e274e8, topicName=TENS)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3b172500206, createdName=12498ebem19暂无昵称, createdTime=Wed Jun 26 12:50:00 CST 2019, time=2019-06-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1291986, encodeId=87f412919867b, content=<a href='/topic/show?id=9d32981418b' target=_blank style='color:#2F92EE;'>#降压#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=98141, encryptionId=9d32981418b, topicName=降压)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8f14236, createdName=经常头晕, createdTime=Fri Aug 17 00:50:00 CST 2018, time=2018-08-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1501323, encodeId=259a1501323c3, content=<a href='/topic/show?id=f2db9238f9' target=_blank style='color:#2F92EE;'>#Hypertension#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=9238, encryptionId=f2db9238f9, topicName=Hypertension)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=11ff9497046, createdName=jambiya, createdTime=Fri Aug 17 00:50:00 CST 2018, time=2018-08-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=338752, encodeId=40ae338e5241, content=儿童高血压的治疗。, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/07/16/3b24606172648eea459125cb74754afe.jpg, createdBy=6c022216608, createdName=liumin1987, createdTime=Wed Aug 15 11:39:24 CST 2018, time=2018-08-15, status=1, ipAttribution=)]
  5. [GetPortalCommentsPageByObjectIdResponse(id=1727531, encodeId=df131e2753186, content=<a href='/topic/show?id=986913980dd' target=_blank style='color:#2F92EE;'>#PE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13980, encryptionId=986913980dd, topicName=PE)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f06c33759375, createdName=feather89, createdTime=Mon Apr 29 04:50:00 CST 2019, time=2019-04-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2038965, encodeId=eb2320389654e, content=<a href='/topic/show?id=b45d1e274e8' target=_blank style='color:#2F92EE;'>#TENS#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17274, encryptionId=b45d1e274e8, topicName=TENS)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3b172500206, createdName=12498ebem19暂无昵称, createdTime=Wed Jun 26 12:50:00 CST 2019, time=2019-06-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1291986, encodeId=87f412919867b, content=<a href='/topic/show?id=9d32981418b' target=_blank style='color:#2F92EE;'>#降压#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=98141, encryptionId=9d32981418b, topicName=降压)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8f14236, createdName=经常头晕, createdTime=Fri Aug 17 00:50:00 CST 2018, time=2018-08-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1501323, encodeId=259a1501323c3, content=<a href='/topic/show?id=f2db9238f9' target=_blank style='color:#2F92EE;'>#Hypertension#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=9238, encryptionId=f2db9238f9, topicName=Hypertension)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=11ff9497046, createdName=jambiya, createdTime=Fri Aug 17 00:50:00 CST 2018, time=2018-08-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=338752, encodeId=40ae338e5241, content=儿童高血压的治疗。, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/07/16/3b24606172648eea459125cb74754afe.jpg, createdBy=6c022216608, createdName=liumin1987, createdTime=Wed Aug 15 11:39:24 CST 2018, time=2018-08-15, status=1, ipAttribution=)]
    2018-08-15 liumin1987

    儿童高血压的治疗。

    0

相关资讯

Hypertension:1995年-2014年,中国青少年超重、肥胖和高血压发病率的变化趋势

Dong Yanhui等研究人员对20年来中国儿童和青少年超重、肥胖和高血压(HBP)的长期趋势进行了评估,并于近日发表在《Hypertension》杂志上。研究数据来源于1995年-2014年中国学生体质健康调查的943 128位7-17岁的学生。超重的发生率从1995年的4.3%增加至2014年的18.4%,而HBP发病率在4.4%-6.4%之间波动,2005年时最低。1995年-2014年,

5类高血压常用药被召回,所有医疗机构停用!

一、缬沙坦原料药检出微量N-亚硝基二甲胺7月29日,国家药监局新闻发言人介绍浙江华海药业股份有限公司(以下简称华海药业)缬沙坦原料药中检出微量N-亚硝基二甲胺(NDMA)杂质有关情况。在此之前,华海药业已于7月6日向国家药监局报告在用于出口的缬沙坦原料药中检出微量N-亚硝基二甲胺(NDMA)杂质的情况,并采取积极措施主动召回。目前,欧盟等多国药品监管机构认为,NDMA属于2A类致癌物(即动物实验

19岁女性已经高血压5年 病因迟迟难以确定

19岁年轻女性,年纪轻轻,已有5年高血压病史。根据该患者病史特点,考虑继发性高血压的可能性大。根据临床表现、实验室检查和B超检查可以排除肾性高血压、内分泌性高血压,也可以排除药物因素及甲状腺功能异常引起的血压升高。那么,该患者究竟患有何病呢?

J Periodontol:抑制I型血管紧张素II受体可以阻止牙周炎炎症及骨缺失

牙周疾病的特点为牙槽骨的破坏以及牙周膜(PDL)的退行性损伤;它始发于口腔细菌的感染,但是它的临床影响却会晚于异常宿主的免疫反应。在全世界范围内,原发性高血压(PH)会引起显著升高的发病率和死亡率,基于其异常的免疫细胞浸润和活性,它也被认为是一种炎症性疾病。临床回顾性研究显示,PH与牙周炎存在一定的联系,PH会加重牙周炎,反之亦然。然而,造成这种情况的病理生理学机制还未可知。

当高血压遇上高尿酸:千万不可忽视

高尿酸血症和痛风一般发作于中年人群体,特别是中年男子群体的发病率居高不下。同时可以发现,这些由于饮食结构导致的高尿酸血症患者也常常伴随着“三高”——高血压、高血脂、高血糖。据统计,有20%的高尿酸血症患者同时患有高血压,而高血压患者中有大概三分之一患有高尿酸血症。很多人都把这两种病单独看待,而事实是,高血压和高尿酸血症的病情变化和治疗是相互影响的。

SCI REP:老年高血压患者认知障碍与较差抗高血压药物依从性之间的关系

该研究的结果表明即使在没有痴呆症的患者中,认知障碍也是抗高血压药物治疗依从性较差的可能危险因素。因此,参与老年护理的临床医生应该监测患者的认知功能和药物依从性。如果患者出现认知障碍,临床医生需要教育患者和护理人员关于抗高血压药物治疗依从性的重要性,并考虑采取适当的干预措施来改善老年患者的认知功能。